Background Atrial fibrillation is a leading preventable cause of recurrent stroke for which
early detection and treatment are critical. However, paroxysmal atrial fibrillation is often …

Measurement of recovery after stroke is becoming increasingly important with the advent of
new treatment options under investigation in stroke rehabilitation research. The Fugl-Meyer …

Background— Neuroprotective drugs for acute stroke have appeared to work in animals,
only to fail when tested in humans. With the failure of so many clinical trials, the future of …

Approximately 10% of ischemic strokes are associated with atrial fibrillation (AF) first diagnosed
at the time of stroke. Detecting asymptomatic AF would provide an opportunity to prevent …

The Canadian Cardiovascular Society (CCS) atrial fibrillation (AF) guidelines program was
developed to aid clinicians in the management of these complex patients, as well as to …

Background In patients with intracerebral haemorrhage (ICH), early haemorrhage expansion
affects clinical outcome. Haemostatic treatment reduces haematoma expansion, but fails to …

Background and Purpose— Morbidity and mortality in spontaneous intracerebral hemorrhage
(ICH) are correlated with hematoma progression. We hypothesized that the presence of …

Background and Purpose— Warfarin is the most effective stroke prevention medication for
high-risk individuals with atrial fibrillation, yet it is often underused. This study examined the …

Background Intravenous thrombolysis with alteplase bolus followed by infusion is a global
standard of care for patients with acute ischaemic stroke. We aimed to determine whether …

Atrial fibrillation (AF) is an extremely common clinical problem with an important population
morbidity and mortality burden. The management of AF is complex and fraught with many …